(20371917), S. K. (2025). Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells.
Cita Chicago Style (17a ed.)(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
Cita MLA (9a ed.)(20371917), Sushil Kumar. Supplementary Figure 5: Pathway Analysis After Treatment with KC and KCM Serum in Precursor Cells. 2025.
Precaución: Estas citas no son 100% exactas.